KVUE Kenvue Inc.

$15.85

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Kenvue, Inc. (KVUE) is poised to capture investor attention as it approaches its earnings announcement on July 17, 2025, with a market cap of over $40 billion underscoring its significant presence in the industry. Analysts are eyeing an EPS estimate of $0.28, while the whisper number suggests a slightly more optimistic outlook at $0.30, indicating a potential upside surprise. The revenue estimate stands at $3.94 billion, reflecting the company's robust market position and strategic initiatives aimed at sustaining growth. Despite the absence of recent news, Kenvue's consistent performance and strategic focus on innovation and market expansion are likely to be key themes in the upcoming earnings call. Investors will be keen to see if Kenvue can exceed expectations and align with the whisper number, which could further bolster market confidence in its growth trajectory.

Updated On 10/2/2025

About Kenvue Inc.

Kenvue Inc. is a consumer health company globally.

Website: https://www.kenvue.com

Sector
LIFE SCIENCES
Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1944048
Address
199 GRANDVIEW ROAD, SKILLMAN, NJ, UNITED STATES
Valuation
Market Cap
$44.88B
P/E Ratio
43.31
PEG Ratio
2.39
Price to Book
4.64
Performance
EPS
$0.54
Dividend Yield
3.51%
Profit Margin
6.67%
ROE
9.87%
Technicals
50D MA
$22.76
200D MA
$21.91
52W High
$24.36
52W Low
$17.18
Fundamentals
Shares Outstanding
2B
Target Price
$24.21
Beta
nan

KVUE EPS Estimates vs Actual

Estimated
Actual

KVUE News & Sentiment

Oct 01, 2025 • Motley Fool NEUTRAL
Should You Buy Kenvue Stock After Its 30% Plunge?
There hasn't been much good news lately for this Johnson & Johnson spinoff.
Oct 01, 2025 • Motley Fool SOMEWHAT-BULLISH
Cullen Trims KVUE Stake With $149.5M Share Sale
Cullen Capital Management, LLC disclosed the sale of 6,565,339 shares of Kenvue ( NYSE:KVUE ) for the period ended Q2 2025. The transaction was valued at an estimated $149.46 million.Cullen Capital Management, LLC reported in a September 30, 2025SEC filingthat it reduced its position in Kenvue by ...
Sep 28, 2025 • Motley Fool SOMEWHAT-BULLISH
Why Johnson & Johnson Could Be the Ultimate Dividend King
Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.
Sep 26, 2025 • Benzinga NEUTRAL
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend…' - Kenvue ( NYSE:KVUE )
A 2017 post by Tylenol on X ( formerly Twitter ) highlighted by White House has fueled a buzz around President Donald Trump's claim that the drug is linked with autism in kids.
Sep 25, 2025 • Benzinga SOMEWHAT-BULLISH
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity - Johnson & Johnson ( NYSE:JNJ )
Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson ( NYSE: JNJ ) revealed 17 unusual trades. Delving into the details, we found 58% of traders were bullish, while 23% showed bearish tendencies.
Sep 24, 2025 • Benzinga SOMEWHAT-BULLISH
Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning - Kenvue ( NYSE:KVUE )
Kenvue Inc. KVUE saw its stock rise by 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns stirred by President Trump's controversial comments about acetaminophen potentially being linked to autism. Check out the current price of KVUE stock here.
Sentiment Snapshot

Average Sentiment Score:

0.071
50 articles with scored sentiment

Overall Sentiment:

Neutral

KVUE Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 06, 2025
Dec 31, 2024 (Pre market)
-0.05 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.31
  • Whisper:
  • Surprise %: -16.1%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.27
  • Whisper:
  • Surprise %: 3.7%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 14.3%
May 07, 2024
Mar 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.26
  • Whisper:
  • Surprise %: 7.7%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 10.7%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.31
  • Whisper:
  • Surprise %: 0.0%
Jul 20, 2023
Jun 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.30
  • Whisper:
  • Surprise %: 6.7%
Jun 02, 2023
Mar 31, 2023 (Post market)
-0.13 Surprise
  • Reported EPS: $0.19
  • Estimate: $0.32
  • Whisper:
  • Surprise %: -40.6%

Financials